Zurcher Kantonalbank Zurich Cantonalbank Has $2.07 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)

Zurcher Kantonalbank Zurich Cantonalbank reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,580 shares of the company’s stock after selling 946 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in HealthEquity were worth $2,071,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HQY. Assetmark Inc. lifted its holdings in HealthEquity by 457.5% in the third quarter. Assetmark Inc. now owns 4,544 shares of the company’s stock valued at $372,000 after buying an additional 3,729 shares during the period. GSA Capital Partners LLP acquired a new position in HealthEquity in the third quarter valued at approximately $638,000. KBC Group NV lifted its holdings in HealthEquity by 16.1% in the third quarter. KBC Group NV now owns 2,463 shares of the company’s stock valued at $202,000 after buying an additional 341 shares during the period. Natixis Advisors LLC increased its stake in HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock valued at $17,122,000 after purchasing an additional 48,009 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. increased its stake in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after purchasing an additional 226,563 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Raymond James upped their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, JMP Securities upped their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $112.92.

HealthEquity Stock Performance

Shares of HQY opened at $97.41 on Monday. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a fifty day simple moving average of $105.68 and a 200 day simple moving average of $95.35. The stock has a market capitalization of $8.44 billion, a price-to-earnings ratio of 89.37, a PEG ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.20% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.